Navigation Links
Drug Users Are 'Super-Spreaders' of Hepatitis C, Study Finds
Date:1/31/2013

THURSDAY, Jan. 31 (HealthDay News) -- Each injection drug user with hepatitis C is likely to infect about 20 other people, and half of those transmissions occur in the first two years after the initial infection, new research shows.

The findings indicate that early diagnosis and treatment of hepatitis C in injection drug users -- called "super-spreaders" -- could prevent many cases of hepatitis C, the researchers said.

The hepatitis C virus is spread through contact with infected blood, having sex with an infected person and from mother to baby during childbirth. Hepatitis C can lead to scarring of the liver or liver cancer. Some patients require a liver transplant. There is no vaccine for the disease.

The researchers combined epidemiological and molecular data to determine how hepatitis C spreads in a population.

"For the first time we show that super-spreading in hepatitis C is led by intravenous drug users early in their infection," study author Gkikas Magiorkinis, of the zoology department at the University of Oxford in England, said in a university news release.

"Using this information, we can hopefully soon make a solid argument to support the scaling-up of early diagnosis and antiviral treatment in drug users," Magiorkinis said. "Helping these people and stopping the spread of hepatitis C is our ultimate target."

The study was published Jan. 31 in the journal PLoS Computational Biology.

Up to 180 million people worldwide are infected with hepatitis C, but many don't know it and go undiagnosed for more than 10 years.

"Working out how many people are likely to be infected by each 'super-spreader' of hepatitis C, as well as how soon they will be infected, has been a puzzle for over 20 years," Magiorkinis said.

"Our research has resolved this issue and paves the way for a modeling study to show what kind of public health interventions could really make a difference," he added. He said their approach should also be useful to those studying HIV.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about hepatitis C.

-- Robert Preidt

SOURCE: University of Oxford, news release, Jan. 31, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
2. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or Other Serious Medical Issues to Call the Johnson Law Group-ASAP
3. Bundlevid.Me: New Apple iPhone App Bundlevid Brings Easy Video Journaling to iPhone Users
4. US Drug Watchdog Now Urges Users of Yaz or Yasmin Birth Control Pills Who Suffered A Life Threatening Medical Problem To Call The Johnson Law Group-Immediately
5. The US Drug Watchdog Now Urges Users Of The Birth Control Pills Yaz-Yasmin to Contact The Johnson Law Group For a Legal Review if They Developed Severe Medical Problems
6. New ChairMaster™ Fitness Chair Lets Users Sit and Get Fit
7. Voice Activated PDA for Blind and Low Vision Users from LS&S Now Offered by Rehabmart
8. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Stroke, Blood Clots, or a Heart Attack to Call the Johnson Law Group for a Legal Review
9. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
10. myMEDholiday Comes up with a New Highly Credible Informative Website for Users Looking for Affordable Healthcare Centers Abroad
11. Kids With Autism Common Users of ERs, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Users Are 'Super-Spreaders' of Hepatitis C, Study Finds
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: